Home NDC 27241-299 Topiramate
Product NDC 27241-299
11-digit product format 272410299
Labeler code 27241
Product ID 27241-299_a64af809-588a-4986-93e6-99fe5a7537cf
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Topiramate
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Ajanta Pharma USA Inc.
Application ANDA219564
Marketing category ANDA
Marketing start 2025-09-02
Substance TOPIRAMATE
Active strength 150 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219564-001 TOPIRAMATE TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 A219564-002 TOPIRAMATE TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 A219564-003 TOPIRAMATE TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 A219564-004 TOPIRAMATE TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 A219564-005 TOPIRAMATE TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A219564-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A219564-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A219564-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A219564-004 TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A219564-005 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 A219564-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A219564-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A219564-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A219564-004 TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A219564-005 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A219564-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219564-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219564-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219564-004 TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219564-005 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219564-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219564-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219564-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219564-004 TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219564-005 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219564-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219564-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219564-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219564-004 TOPIRAMATE 150MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219564-005 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB2 2025-09-02 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Topiramate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TOPIRAMATE 150 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 27241-299-30 Topiramate 30 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 30 5
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 27241-299-30 27241029930 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-299-30) 2025-09-02 No No Current